Clinical Trials

Showing trials with last updates posted in 2013.

NCT01765933 | COMPLETED | NA
8 participants

Pharmacokinetic Effects of Oral DMAA

Study Type:
INTERVENTIONAL
Last Updated:
2013-01-11
Start Date:
2012-04-30
Completion:
2012-05-31
Conditions
  • Outcomes of Single Oral Dose
Interventions
  • DIETARY_SUPPLEMENT
No Results Yet
NCT00335998 | COMPLETED | PHASE1
24 participants

Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2013-01-11
Start Date:
2006-03-31
Completion:
2008-10-31
Conditions
  • Recurrent Cervical Cancer
  • Recurrent Ovarian Epithelial Cancer
  • Recurrent Vaginal Cancer
  • Recurrent Vulvar Cancer
  • Stage III Vaginal Cancer
  • Stage IIIA Cervical Cancer
  • Stage IIIA Ovarian Epithelial Cancer
  • Stage IIIA Vulvar Cancer
  • Stage IIIB Cervical Cancer
  • Stage IIIB Ovarian Epithelial Cancer
  • Stage IIIB Vulvar Cancer
  • Stage IIIC Ovarian Epithelial Cancer
  • Stage IIIC Vulvar Cancer
  • Stage IV Ovarian Epithelial Cancer
  • Stage IVA Cervical Cancer
  • Stage IVA Vaginal Cancer
  • Stage IVB Cervical Cancer
  • Stage IVB Vaginal Cancer
Interventions
  • DRUG
  • OTHER
  • RADIATION
No Results Yet
NCT00098826 | COMPLETED | PHASE1
40 participants

SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes

Study Type:
INTERVENTIONAL
Last Updated:
2013-01-11
Start Date:
2004-12-31
Completion:
2008-05-31
Conditions
  • Acute Undifferentiated Leukemia
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • Adult Acute Minimally Differentiated Myeloid Leukemia (M0)
  • Adult Acute Monoblastic Leukemia (M5a)
  • Adult Acute Monocytic Leukemia (M5b)
  • Adult Acute Myeloblastic Leukemia With Maturation (M2)
  • Adult Acute Myeloblastic Leukemia Without Maturation (M1)
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
  • Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
  • Adult Acute Myelomonocytic Leukemia (M4)
  • Adult Acute Promyelocytic Leukemia (M3)
  • Adult Erythroleukemia (M6a)
  • Adult Pure Erythroid Leukemia (M6b)
  • Blastic Phase Chronic Myelogenous Leukemia
  • de Novo Myelodysplastic Syndromes
  • Previously Treated Myelodysplastic Syndromes
  • Recurrent Adult Acute Lymphoblastic Leukemia
  • Recurrent Adult Acute Myeloid Leukemia
  • Refractory Anemia With Excess Blasts
  • Refractory Anemia With Excess Blasts in Transformation
  • Relapsing Chronic Myelogenous Leukemia
  • Secondary Acute Myeloid Leukemia
  • Secondary Myelodysplastic Syndromes
  • Untreated Adult Acute Myeloid Leukemia
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00003166 | COMPLETED | PHASE1
18 participants

Bryostatin and Vincristine in B-Cell Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2013-01-11
Start Date:
1998-05-31
Completion:
2001-07-31
Conditions
  • Recurrent Adult Burkitt Lymphoma
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Recurrent Adult Diffuse Mixed Cell Lymphoma
  • Recurrent Adult Immunoblastic Large Cell Lymphoma
  • Recurrent Adult Lymphoblastic Lymphoma
  • Recurrent Grade 3 Follicular Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Multiple Myeloma
  • Stage III Multiple Myeloma
Interventions
  • DRUG
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page